Nelson S. Yee

Pennsylvania State University — United States

Medicine · Health Sciences

33h-index4.0kcitations123works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(27), Hepatocellular Carcinoma Treatment and Prognosis(16), Cancer Genomics and Diagnostics(15), Magnesium in Health and Disease(13), Cancer Immunotherapy and Biomarkers(11)

Publications123 total

Phase II Study of Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and Fluorouracil in Locally Advanced Pancreatic Carcinoma: BTCRC-GI15-067
JCO oncology advances.·2025Open Access
Towards Collaborative Fairness in Federated Learning Under Imbalanced Covariate Shift
2025Open Access
Editorial: Clinical implementation of precision oncology data to direct individualized and immunotherapy-based treatment strategies
Frontiers in Immunology·2025· 1 citedOpen Access
Comprehensive Analysis of Granzymes and Perforin Family Genes in Multiple Cancers
Biomedicines·2025· 4 citedOpen Access
Machine Intelligence in Pancreatic Cancer
2025
Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post-Transcatheter Arterial Embolization
Journal of Clinical Medicine·2024· 3 citedOpen Access
Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma post Transcatheter Arterial Chemoembolization 
2024· 1 citedOpen Access
A review on cell-free RNA profiling: Insights into metabolic diseases and predictive value for bariatric surgery outcomes
Molecular Metabolism·2024· 8 citedOpen Access
Complete response to chemotherapy in a 6-year survivor of metastatic pancreatic cancer
BMJ Case Reports·2024· 1 cited
Utilizing nullomers in cell-free RNA for early cancer detection
Cancer Gene Therapy·2024· 14 citedOpen Access
Peptide absent sequences emerging in human cancers
European Journal of Cancer·2023· 12 cited
Machine Intelligence in Pancreatic Cancer
2023
Nab-Paclitaxel and Gemcitabine as First-Line Treatment of Metastatic Ampullary Adenocarcinoma with a Novel R-Spondin2 RNA Fusion and NTRK3 Mutation
Biomedicines·2023· 1 citedOpen Access
Impact of Colorectal Cancer Sidedness and Location on Therapy and Clinical Outcomes: Role of Blood-Based Biopsy for Personalized Treatment
Journal of Personalized Medicine·2023· 9 citedOpen Access
Utilizing nullomers in cell-free RNA for early cancer detection
2023· 5 citedOpen Access
American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma
American Journal of Clinical Oncology·2022· 4 citedOpen Access
Abstract CT246: Phase 1b/2 study of giloralimab in combination with modified FOLFIRINOX with or without budigalimab in patients with untreated metastatic pancreatic cancer
Cancer Research·2022
Molecular profile of hepatocellular carcinoma (HCC) in older versus younger adults: Does age matter?
Journal of Clinical Oncology·2022
Machine intelligence for precision oncology
World Journal of Translational Medicine·2021· 2 citedOpen Access
Drug–Microbiota Interaction in Colon Cancer Therapy: Impact of Antibiotics
Biomedicines·2021· 22 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Michael Pack(7), Peter Besmer(6), Weiqiang Zhou(6), Rosemary K. Yee(6), Abid A. Kazi(3), Edward P. Balaban(2), Pamela B. Mangu(2), Hubert Serve(2), Giulia Maria Stella(2), Keith Vosseller(2), John Lin(2), Andrew V. Biankin(2), Marko E. Horb(2), Bidyut Ghosh(2), Nijaguna B. Prasad(2), Steven D. Leach(2), Kristin Lorent(2), I-Chau Liang(2), Joanne Xiu(2), Zoran Gatalica(2)